Concepedia

Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytes

Hwan‐Jin Hwang, Tae Woo Jung, Ja Young Ryu, Ho Cheol Hong, Hae Yoon Choi, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Kyung Mook Choi, Dong Seop Choi,

Molecular and Cellular Endocrinology · 2014 · 32 citations · 24 references

DOI

Concepts

References

24

Coupling of Stress in the ER to Activation of JNK Protein Kinases by Transmembrane Protein Kinase IRE1

Fumihiko Urano, Xiao-Zhong Wang, Anne Bertolotti et al. · Science · 2000 · 3K citations

, , +16

The Independent Effect of Type 2 Diabetes Mellitus on Ischemic Heart Disease, Stroke, and Death

Thomas Almdal, Henrik Scharling, Jan Skov Jensen et al. · Archives of Internal Medicine · 2004 · 647 citations

, , +17

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk et al. · European Heart Journal · 2011 · 546 citations · Full text

, , +16

Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 Diabetes

James Mu, John Woods, Yun-Ping Zhou et al. · Diabetes · 2006 · 450 citations · Full text

, , +17

The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes

Gian Paolo Fadini, Elisa Boscaro, Mattia Albiero et al. · Diabetes Care · 2010 · 321 citations · Full text

, , +15